The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: Retrospective analysis of 60 patients

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2353-2359

  Yamashita, Yo Ichi ^a   Taketomi, Akinobu ^a   Morita, Kazutoyo ^a   Fukuhara, Takasuke ^a   Ueda, Shigeru ^a   Sanefuji, Kensaku ^a   Iguchi, Tomohiro ^a   Kayashima, Hiroto ^a   Sugimachi, Keishi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Lymph node dissection; Poor prognostic factors; R0 resection

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 48849112571     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211: 277-287, 1990.
2. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O and Kinoshita H: Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 88: 969-74, 2001.
3. Chou FF, Sheen-Chen SM, Chen YS, Chen MC and Chen CL: Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44: 760-765, 1997.
4. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF and Belghiti J: Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 6: 122-127, 1999.
5. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H and Yokoi H: Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6: 108-116, 1999.
6. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C and Maddern G: Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25: 375-380, 1999.
7. Kawarada Y and Mizumoto R: Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 37: 176-181, 1990.
8. Pichlmayr R, Lamesch P, Weimann A, Tusch G, and Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 19: 83-88, 1995.
9. Berdah SV, Delpero JR, Garcia S, Hardwigsen J and Le Treut YP: A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 83: 1517-1521, 1996.
10. Lang H, Sotiropoulos GC, Frühauf NR, Dömland M, Paul A, Kind EM, Malagó M and Broelsch CE: Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 241: 134-143, 2005.
11. Kim HJ, Yun SS, Jung KH, Kwun WH and Choi JH: Intrahepatic cholangiocarcinoma in Korea. J Hepatobiliary Pancreat Surg 6: 142-148, 1999.
12. Chu KM and Fan ST: Intrahepatic cholangiocarcinoma in Hong Kong. J Hepatobiliary Pancreat Surg 6: 149-153, 1999.
13. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K and Nakano M: Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Sug Oncol 69: 162-167, 1998.
14. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K and Sugimachi K: Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88: 1463-1466, 2001.
15. Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C, Tusch G and Raab R: Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellualr carcinoma. Br J Surg 87: 1182-1187, 2000.
16. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H and Miyazaki M: Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89: 1525-1531, 2002.
17. Yamamoto M, Takasaki K and Yoshikawa T: Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6: 117-121, 1999.
18. Liver Cancer Study Group of Japan: Classification of Primary Liver Cancer. 1st English ed. Tokyo: Kanehara, 1997.
19. Sobin LH and Wittekind CH (eds.): TNM Classification of Malignant Tumors (6th ed.). New York, NY, Wiley-Liss, 2002.
20. Washburn WK, Lewis WD and Jenkins RL: Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130: 270-276, 1995.
21. Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM and Schwartz ME: Aggressive surgical treatment of intrahepatic cholangio-carcinoma: predictors of outcomes. J Am Coll Surg 187: 365-372, 1998.
22. Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D, Julien M and Fagniez PL: Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 130: 1073-1078, 1995.
23. Chu KM, Lai EC, Al-Hadeedi S, Arcilla CE Jr, Lo CM, Liu CL, Fan ST and Wong J: Intrahepatic cholangiocarcinoma. World J Surg 21: 301-303, 1997.
24. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, Pinna A, Dvorchik I, Fung JJ and Starzl TE: Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185: 429-436, 1997.
25. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y and Furukawa M: Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 181: 507-511, 2001.
26. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M, Kinoshita T, Miyagawa S and Kawasaki S: Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127: 498-505, 2000.
27. Murakami Y, Yokoyama T, Takesue Y, Hiyama E, Yokoyama Y, Kanehiro T, Uemura K and Matsuura Y: Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery 127: 105-106, 2000.
28. Yamamoto M, Takasaki K, Imaizumi T, Ariizumi S, Matsumura N and Nakano M: A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. Jpn J Clin Oncol 32: 206-209, 2002.
29. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y and Blumgart LH: Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193: 384-391, 2001.
30. Harimoto N, Shimada M, Tsujita E, Maehara S, Rikimaru T, Yamashita Y, Maeda T, Tanaka S, Shirabe K and Sugimachi K: Laparoscopic hepatectomy and dissection of lymph nodes for intrahepatic cholangiocarcinoma. Case report. Surg Endosc 16: 1806, 2002.
31. Kubicka S, Rudolph KL, Tietze MK, Lorenz M and Manns M: Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 48: 783-789, 2001.
32. Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, Depisch D, Krauss G, Schneeweiss B and Scheithauer W: Phase II trial of two-weekly gemcitabine in patients with advanced biliary tree cancer. Ann Oncol 12: 183-186, 2001.
33. Lee J, Kim TY, Lee MA, Ahn MJ, Kim HK, Lim HY, Lee NS, Park BJ and Kim JS; on behalf of the Korean Cancer Study Group: Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemother Pharmacol 61: 47-52, 2008.
34. Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH, Heo JS, Park YS, Kang WK and Park K: A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106: 1339-1346, 2006.
35. Yamashita Y, Taketomi A, Fukuzawa K, Yoshizumi T, Uchiyama H, Simada M, Shirabe K, Wakasugi K and Maehara Y: Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study. Anticancer Res 26: 771-775, 2006.
36. Harrison LE, Fong Y, Klimstra DS, Zee SY and Blumgart LH: Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85: 1068-1070, 1998.
37. Jan YY, Jeng LB, Hwang TL, Wang CS, Chen MF and Chen TJ: Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology 43: 614-619, 1996.
38. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W and Starzl TE: Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227: 70-79, 1998.
39. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, Yamazaki S, Hasegawa H and Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107: 521-527, 1990.
40. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T and Nimura Y: Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Ann Surg 243: 364-372, 2006.